Bio-Techne Corp (TECH)
Nasdaq: TECH · Biological Products, (No Diagnostic Substances) · Minneapolis, MN · filing with the SEC since 1995
Grade6.3
◀ Past 7.2● Present 7.3▶ Future 4.2
Who owns Bio-Techne Corp
As filed with the SECHolders of 5% or more
3
Fmr LLC holds 8.1% of COMMON STOCK, as its SCHEDULE 13G/A filed Aug 6, 2026 says.
Directors and officers
15
report now, of 26 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · COMMON STOCK · 5% in May 6, 2026
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 16, 2025 · Common Stock
T. Rowe Price Associates, Inc.
SCHEDULE 13G/A · filed Nov 14, 2025 · COMMON STOCK · reported falling below 5%, from 5.6% in Aug 14, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What TECH reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Wilson Wolf Corporation
An investee · investee · invested in, named in the 10-K filed Aug 24, 2026
Lunaphore Technologies SA
A company bought · acquisition · Jun 2024 · owns, named in the 10-K filed Aug 24, 2026
11 subsidiaries in 5 countries, from the list filed with the 10-K filed Aug 24, 2026.
Insider tradesForm 4
2sales
0purchases
0sales on a scheduled plan
1people selling
$400,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 3, 2025 to Nov 3, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 3, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 26 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Herr Amy E. | director | 2 | $400,000 | 0 | 0 | $0 |